Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Business Overview: The Company provides Gamma Knife radiosurgery units to medical centers. As of March 31, 2004, it operated 17 units across 14 states. Revenue models include fee-per-use contracts (13 customers) and revenue-sharing "retail" agreements (4 customers).
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Revenues | $4,229,000 | $3,669,000 |
| Operating Income | $817,000 | $727,000 |
| Net Income | $370,000 | $336,000 |
| Diluted EPS | $0.07 | $0.07 |
| Cash from Operations | $1,844,000 | $2,152,000 |
| Cash and Equivalents (End of Period) | $10,062,000 | $11,341,000 |
| Total Debt (Current + Long-term) | $25,226,000 | N/A |
| Working Capital | $5,076,000 | N/A |
Note: Total Debt calculated as Current portion of long-term debt ($6,873,000) + Long-term debt less current portion ($18,353,000).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased by $560,000 (15.3%) primarily due to three new Gamma Knife units added in 2003. However, revenue at units operating for over one year decreased by 9% due to the death and sabbatical of key neurosurgeons at two locations.
- Procedure Volume: Total procedures increased by 73 to 563. Excluding the two affected units, procedures at mature units increased by 5%.
- Operating Costs: Total costs of operations rose $499,000. Increases were driven by depreciation ($238,000 increase) and other direct operating costs ($203,000 increase) related to new units and marketing.
- Selling & Administrative: Costs decreased by $60,000 due to staff reductions in sales and marketing, offsetting a $58,000 write-off of deferred costs in the prior year.
- Interest Expense: Increased by $31,000 due to financing for new units, partially offset by declining interest on mature loans.
Outlook, Risks, and Management Commentary
- Liquidity: Cash decreased by $250,000 due to capital expenditures ($176,000) and dividend payments ($157,000). Management believes cash flow and resources are adequate to meet scheduled debt obligations of approximately $8.9 million over the next 12 months.
- Dividends: The Company declared a quarterly dividend of $0.04 per share on February 12, 2004, payable April 16, 2004.
- Financing Risk: The Company's primary lender, DVI Financial Services Inc., filed for Chapter 11 bankruptcy in August 2003. While existing financing is not materially affected, there is no assurance that future financing will be secured on terms as favorable as those historically provided by DVI.
- Forward-Looking Statements: Risks include the development of IMRT and "The Operating Room for the 21st Century" programs, as well as general risks associated with the Gamma Knife business.
Investor Verification Checklist
- Key Personnel Dependency: Verify the status of neurosurgeon recruitment at the two locations affected by death and sabbatical, as this directly impacted mature unit revenue.
- Financing Strategy: Confirm the status of new financing arrangements given the bankruptcy of primary lender DVI Financial Services Inc.
- Debt Service Coverage: Review the ability to service $8.86 million in scheduled debt payments over the next 12 months against current operating cash flows.
- Unit Utilization: Monitor procedure volume trends at the 14 mature units to ensure the 9% revenue decline is not a structural trend.